Belapzo belongs to the group of drugs used to treat cancer and contains Bendamustine, which is administered intravenously. Belapzo is indicated for the treatment of chronic Lymphocytic leukemia and B-cell non-Hodgkin's lymphoma in patients already receiving other therapies.

Cladribine is a cancer chemotherapy that helps treat hairy cell leukemia, chronic lymphocytic leukemia, or recurrent multiple sclerosis. However, patients using Cladribine must be aware of side effects.